Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate

Inflammatory Bowel Diseases

Volumn 16, Issue 7, 2010, Pages 1138-1148

  Lewis, Kimberley ^a   Lutgendorff, Femke ^b   Phan, Van ^a   Söderholm, Johan D ^b   Sherman, Philip M ^c   McKay, Derek M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Commensal microflora; Energy; Intestine; NF B; Permeability; Pseudopodia; Signaling

Indexed keywords

2,4 DINITROPHENOL; BUTYRIC ACID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; BACTERIAL TRANSLOCATION; COLON MUCOSA; CONTROLLED STUDY; ENTERITIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; INTESTINE FUNCTION; MEMBRANE PERMEABILITY; METABOLIC STRESS; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSCYTOSIS; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIAL TRANSLOCATION; BUTYRATES; CELL LINE; CELL MEMBRANE PERMEABILITY; COLON; DINITROPHENOLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GLUCOSE; HUMANS; IMMUNOBLOTTING; INTESTINAL MUCOSA; MITOCHONDRIA; NF-KAPPA B; PHOSPHORYLATION; SALMONELLA TYPHIMURIUM; STRESS, PHYSIOLOGICAL;

EID: 77953721898     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21177     Document Type: Article

References (51)

1. Laukoetter MG, Nava P, Nusrat A. Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol. 2008;14:401-407.
2. Turner JR. Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol. 2006;169:1901-1909.
3. Lewis K, McKay DM. Metabolic stress evokes decreases in epithelial barrier function: mechanistic insights from in vitro and in vivo model systems. NY Acad Sci. 2009;1165:327-337.
4. Nazli A, Yang P-C, Jury J, et al. DM. Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol. 2004;164:947-957.
5. Söderholm JD, Olaison G, Peterson KH, et al. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut. 2002;50:307-313.
6. Schurmann G, Bruwer M, Klotz A, et al. Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease. Int J Colorectal Dis. 1999;14:41-46.
7. He D, Hagen SJ, Pothoulakis C, et al. Clostridium difficile toxin A causes early damage to mitochondria in cultured cells. Gastroenterology. 2000;119:139-150.
8. Basivireddy J, Vasudevan A, Jacob M, et al. Indomethacin-induced mitochondrial dysfunction and oxidative stress in villus enterocytes. Biochem Pharm. 2002;64:339-349.
9. Ramachandran A, Patram A, Balasubramanian KA. Intestinal mitochondrial dysfunction in surgical stress. J Surg Res. 2001;99:120-128.
10. Söderholm JD, Yang P-C, Vohra A, et al. Chronic psychological stress induces epithelial barrier disruption, bacterial penetration and mucosal inflammation in the ileum and colon of naive rats. Gastroenterology. 2002;123:1099-1108.
11. Ma C, Wickham ME, Guttman JA, et al. Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Cell Microbiol. 2006;8:1669-1686.
12. Lewis K, Caldwell J, Phan V, et al. Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-a. Am J Physiol Gastrointest Liver Physiol. 2008;294:G669-G678.
13. Nazli A, Wang A, Steen O, et al. Enterocyte cytoskeleton changes are crucial for enhanced translocation of commensal bacteria across metabolically stressed gut epithelia. Infect Immunity. 2006;74:192-201.
14. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434.
15. Keita AV, Salim SY, Jiang T, et al. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease. J Pathol. 2008;215:135-144.
16. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduce diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205-211.
17. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn's disease patients. Proc Natl Acad Sci U S A. 2008;105:16731-16736.
18. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104: 13780-13785.
19. Barcenilla A, Pryde SE, Martin JC, et al. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol. 2000;66:1654-1661.
20. Roediger WE. The colonic epithelium in ulcerative colitis: an energydeficiency disease? Lancet. 1980;2:712-715.
21. McKay DM, Watson JL, Wang A, et al. Phosphatidylinositol 30-kinase is a critical mediator of interferon-gamma-induced increases in enteric epithelial permeability. J Pharmacol Exp Ther. 2007;320:1013-1022.
22. van Niel G, Raposo G, Candalh C, et al. Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology. 2001;121:337-349. (Pubitemid 32729381)
23. Philpott DJ, McKay DM, Sherman PM, et al. Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am J Physiol Gastrointest Liver Physiol. 1996;270:G634-G645. (Pubitemid 126756558)
24. Deitch EA, Xu D, Kaise VL. Role of the gut in the development of injury- and shock-induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci. 2006;11:520-528.
25. De-Souza DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med. 2005;33:1125-1135.
26. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577-594.
27. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15:1183-1189.
28. Cook SI, Sellin JH. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther. 1998;12:499-507.
29. Miller SJ. Cellular and physiological effects of short-chain fatty acids. Mini Rev Med Chem. 2004;4:839-845. (Pubitemid 39200071)
30. Santhanam S, Venkatraman A, Ramakrishna BS. Impairment of mitochondrial acetoacetyl CoA thiolase activity in the colonic mucosa of patients with ulcerative colitis. Gut. 2007;56:1543-1549.
31. Thibault R, De Coppet P, Daly K, et al. Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology. 2007;133:1916-1927.
32. Sasaki M, Sitaraman SV, Babbin BA, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest. 2007;87:1042-1054.
33. Rook GAW, Stannford JL. Give us this day our daily germs. Immunol Today. 1998;19:113-116.
34. Venkatraman A, Ramakrishna BS, Shaji RV, et al. Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and NF-κB. Am J Physiol Gastrointest Liver Physiol. 2003;285:G177-G184.
35. Sauer J, Richter KK, Pool-Zobel BL. Physiological concentrations of butyrate favorably modulate genes of oxidative and metabolic stress in primary human colon cells. J Nutr Biochem. 2007;18:736-745.
36. Segain JP, Raingeard de la BD, Bourreille A, et al. Butyrate inhibits inflammatory responses through NF-κB inhibition: implications for Crohn's disease. Gut. 2000;47:397-403.
37. Yin L, Laevsky G, Giardina C. Butyrate suppression of colonocyte NF-kB activation and cellular proteasome activity. J Biol Chem. 2001; 276:44641-44646.
38. Banan A, Keshavarizan A, Xhang L, et al. NF-jB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. Alcohol. 2007:41:447-460.
39. Banan A, Xhang L, Shaikh M, et al. Novel effect of NF-κB activation. carbonylation and nitration injury to cytoskeleton and disruption of monolayer barrier in intestinal epithelium. Am J Physiol Cell Physiol.l 220;287:C1139-1151.
40. Kumar A, Wu H, Collier-Hyams LS, et al. The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in Cullin-1 neddylation. J Immunol. 2009;182:538-546.
41. Mariadason JM, Barkla DH, Gibson PR. Effect of short chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. Am J Physiol Gastrointest Liver Physiol. 1997;272:G705-G712.
42. Tedelind S, Westberg F, Kjerrulf M, et al. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol. 2007;13:2826-2832. (Pubitemid 47007897)
43. Hoentjen F, Welling GW, Harmsen HJ, et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis. 2005;11:977-985.
44. Looijer-van Langen MA, Dieleman LA. Prebiotics in chronic intestinal inflammation. Inflamm Bowel Dis. 2009;15:454-462.
45. Mariadason JM, Catto-Smith A, Gibson PR. Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats. Gut. 1999;44:394-399. (Pubitemid 29119337)
46. Scheppach W, Sommer H, Kirchner T, et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology. 1992;103:51-56.
47. Okamoto T, Sasaki M, Tsujikawa T, et al. Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats. J Gastroenterol. 2000;35:341-346.
48. Kiely EM, Ajayi NA, Wheeler RA, et al. Diversion procto-colitis: response to treatment with short-chain fatty acids. J Pediatr Surg. 2001;36:1514-1517.
49. Steinhart AH, Hiruki T, Brzezinski A, et al. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther. 1996;10:729-736. (Pubitemid 26340202)
50. Peng L, He Z, Chen W, et al. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res. 2007;61:37-41.
51. Bernstein CN, Walker JR, Graff LA. On studying the connection between stress and IBD. Am J Gastroenterol. 2006;101:782-785.